Research reveals new drug target urgently needed for tuberculosis therapy
One third of the world is infected with the bacterium that causes tuberculosis (TB), a disease that is increasingly difficult to treat because of wide spread resistance to available drugs. Researchers from the Institute of Pharmacology and Structural Biology (CNRS, Université de Toulouse) in Toulouse (France) have identified a fresh target to develop new drugs for TB. The study, published in the Open Access journal PLOS Pathogens, shows why the target will be important in developing new TB treatments.
The deadliest form of human tuberculosis is caused by Mycobacterium tuberculosis (M.tb). The burden of infection continues to increase and every year the world sees 8 million new cases and nearly 2 million deaths. TB, which occurs mostly in developing countries (including China, India and Brazil), drastically hinders economic growth. Current tuberculosis treatments are nearly 50 years old, take more than six months to complete and have many side effects, which makes it difficult for people to take the full course of drugs. The treatments have also become less effective because new bacterial strains are resistant to multiple drugs. There is an urgent need to find drugs with new modes of action that will shorten the duration of treatment, improve ways to fight drug-resistant tuberculosis and treat dormant infections to prevent them from later developing into full blown disease.
The cell envelope of M.tb has an unusually high content of substances called lipids which have unusual composition and are known to play an important role in the causing disease. The production of these disease causing lipids was known to be controlled by the action of a protein which is the enzyme PptT in M.tb.
In this study, the researchers found that production of PptT is needed for growth of M.tb in a culture dish. It is also needed for growth and survival of M.tb in a mouse, which serves as a model for human disease. These findings are the reasons why PptT should be a very good drug target and allow the development of new drugs against TB. The study has also developed a way to quickly test hundreds of thousands of chemical agents (aka drugs) that block the action of Ppt and growth of M.tb. This approach is important and has been used by drug companies to develop drugs to many human diseases.
More information: Leblanc C, Prudhomme T, Tabouret G, Ray A, Burbaud S, et al. (2012) 4'-Phosphopantetheinyl Transferase PptT, a New Drug Target Required for Mycobacterium tuberculosis Growth and Persistence In Vivo. PLoS Pathog 8(12): e1003097. doi:10.1371/journal.ppat.1003097
Journal reference: PLoS Pathogens
Provided by Public Library of Science
- New tuberculosis research movement needed Nov 30, 2011 | not rated yet | 0
- Researchers validate preclinical effectiveness of TB drug target Nov 29, 2011 | not rated yet | 0
- Drug-resistant tuberculosis rife in China Dec 11, 2008 | not rated yet | 0
- Scientists explain unique activity of TB drug pyrazinamide Aug 11, 2011 | not rated yet | 0
- Slow-growing TB bacteria point the way to new drug development Mar 30, 2009 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011 I'd like to open a discussion thread for version 2 of the draft of my book ''Classical and Quantum Mechanics via Lie algebras'', available online at http://lanl.arxiv.org/abs/0810.1019 , and for the...
- More from Physics Forums - Independent Research
More news stories
As the world prepares for what may be the next pandemic strain of influenza virus, in the H7N9 bird flu, a new UC Irvine study reveals that the 2009 H1N1 swine flu pandemic was deadliest for people under the age of 65, while ...
Diseases, Conditions, Syndromes 15 hours ago | not rated yet | 0
The World Health Organization says the Horn of Africa is experiencing an outbreak of polio with cases confirmed in Kenya and Somalia.
Diseases, Conditions, Syndromes 16 hours ago | not rated yet | 0
A man who had contracted the coronavirus has died in Saudi Arabia, raising the death toll in the kingdom from the SARS-like virus to 17, the health ministry announced on its website on Wednesday.
Diseases, Conditions, Syndromes 16 hours ago | not rated yet | 0
A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine ...
Diseases, Conditions, Syndromes 16 hours ago | not rated yet | 0 |
Patients with underlying heart failure are more likely to experience adverse outcomes from mild hypothyroidism, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & ...
Diseases, Conditions, Syndromes 18 hours ago | not rated yet | 0
(Medical Xpress)—Researchers at the University of Virginia School of Medicine have identified a promising target for treating glioblastoma, one that appears to avoid many of the obstacles that typically frustrate efforts ...
55 minutes ago | not rated yet | 0 |
(Medical Xpress)—The first symptoms of major depression may be behavioral, but the common mental illness is based in biology—and not limited to the brain.
49 minutes ago | 5 / 5 (1) | 0 |
(Medical Xpress)—Scientists at Emory Vaccine Center have shown that an immune regulatory molecule called IL-21 is needed for long-lasting antibody responses in mice against viral infections.
43 minutes ago | not rated yet | 0 |
As health services strive to improve quality and reduce costs, researchers study the benefits – and the pitfalls – of 'pay for performance' in hospitals.
4 seconds ago | not rated yet | 0 |
Human breastmilk responds quickly to protect the child when there is an infection in mothers or babies, according to new international research led by The University of Western Australia.
55 minutes ago | not rated yet | 0
(Medical Xpress)—According to the World Health Organization, approximately 70 million couples experience infertility worldwide. Current data suggests that nearly one third of infertility disorders are due ...
10 minutes ago | not rated yet | 0